TissueTech raises $10M for regenerative medicine businesses

08/23/2013 | MassDevice.com (Boston)

TissueTech has secured $10 million in financing from River Cities Capital Funds and Ballast Point Ventures. The Doral, Fla.-based company will use the money to support research and development as well as fund the commercialization of regenerative medicine products developed by its Amniox Medical and Bio-Tissue units.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
CT
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC